1. Home
  2. TRVI vs GES Comparison

TRVI vs GES Comparison

Compare TRVI & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • GES
  • Stock Information
  • Founded
  • TRVI 2011
  • GES 1981
  • Country
  • TRVI United States
  • GES Switzerland
  • Employees
  • TRVI N/A
  • GES N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • GES Apparel
  • Sector
  • TRVI Health Care
  • GES Consumer Discretionary
  • Exchange
  • TRVI Nasdaq
  • GES Nasdaq
  • Market Cap
  • TRVI 1.1B
  • GES 879.0M
  • IPO Year
  • TRVI 2019
  • GES 1996
  • Fundamental
  • Price
  • TRVI $9.64
  • GES $16.80
  • Analyst Decision
  • TRVI Strong Buy
  • GES Buy
  • Analyst Count
  • TRVI 9
  • GES 5
  • Target Price
  • TRVI $20.72
  • GES $19.25
  • AVG Volume (30 Days)
  • TRVI 2.6M
  • GES 534.2K
  • Earning Date
  • TRVI 11-05-2025
  • GES 11-25-2025
  • Dividend Yield
  • TRVI N/A
  • GES 5.35%
  • EPS Growth
  • TRVI N/A
  • GES N/A
  • EPS
  • TRVI N/A
  • GES 0.35
  • Revenue
  • TRVI N/A
  • GES $3,091,508,000.00
  • Revenue This Year
  • TRVI N/A
  • GES $7.74
  • Revenue Next Year
  • TRVI N/A
  • GES $3.47
  • P/E Ratio
  • TRVI N/A
  • GES $48.53
  • Revenue Growth
  • TRVI N/A
  • GES 7.84
  • 52 Week Low
  • TRVI $2.36
  • GES $8.48
  • 52 Week High
  • TRVI $10.16
  • GES $19.91
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 64.43
  • GES 67.26
  • Support Level
  • TRVI $8.24
  • GES $16.67
  • Resistance Level
  • TRVI $8.65
  • GES $16.89
  • Average True Range (ATR)
  • TRVI 0.51
  • GES 0.08
  • MACD
  • TRVI 0.10
  • GES -0.11
  • Stochastic Oscillator
  • TRVI 76.06
  • GES 59.09

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: